CRS3123
CRS3123 is a potent and orally active narrow-spectrum antibiotic. CRS3123 inhibits bacterial methionyl-tRNA synthetase. CRS3123 has potent activity against Clostridium difficile (C. difficile) and aerobic Gram-positive bacteria but little activity against Gram-negative bacteria, including anaerobes. CRS3123 has the potential for the research of C. difficile infections[1].
Product Specifications
CAS Number
1013915-71-3
Product Name Alternative
REP-3123
UNSPSC
12352005
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/crs3123.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
BrC1=C(OCC2)C([C@@H]2NCCCNC3=CC(C(SC=C4)=C4N3)=O)=CC(Br)=C1
Molecular Formula
C19H19Br2N3O2S
Molecular Weight
513.25
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Ataxia Telangiectasia Mutated (ATM) CLIA Kit
Human Ataxia Telangiectasia Mutated (ATM) CLIA Kit
Human Ataxia Telangiectasia Mutated (ATM) CLIA Kit
Recombinant Virus Norovirus Group-2 P-Domain Protein, His, E.coli-1mg